在2型糖尿病相关的牙周炎中,Lactobacillus的机制和应用
Sisi Chen1,2, Yuhan Zhang1,2
1Chongqing Three Gorges Medical College, Chongqing, China.
Frontiers in public health
|December 15, 2023
概括
2型糖尿病 (T2DM) 通过炎症和失生症恶化牙周炎. 乳酸菌通过调节口腔微生物群,在改善T2DM相关牙周炎方面表现有前途,为潜在的临床应用提供了机会.
科学领域:
- 口腔健康 口腔健康
- 内分泌学 在内分泌学.
- 微生物学 微生物学
背景情况:
- 2型糖尿病 (T2DM) 通过炎症,先进的糖化终产物和氧化应激加速牙周炎的进展.
- 糖尿病期间体表现出高葡萄糖和高级糖化终产物,导致疾病的严重程度.
- 由T2DM诱导的肠道微生物群失生症也会影响牙周炎的进展.
研究的目的:
- 总结乳酸菌媒介改善T2DM相关牙周炎的新机制.
- 探索Lactobacillus在管理T2DM相关的口腔健康问题的治疗潜力.
主要方法:
- 文献综述,重点关注乳酸菌在糖尿病和口腔疾病中的作用.
- 对T2DM,牙周炎和口腔微生物群之间的相互作用最近发现的分析.
- 综合证据关于乳酸菌的免疫调节和抗炎作用.
主要成果:
- 乳酸菌微调当地微生物群,抵消T2DM诱导的失生症.
- 有证据表明,Lactobacillus可以减轻T2DM相关牙周炎的炎症和氧化应激.
- 研究强调了Lactobacillus对血糖控制和口腔健康的有益影响.
结论:
- 乳酸菌在改善T2DM相关牙周炎方面显示出显著的潜力.
- 用乳酸菌向口腔微生物群可能为糖尿病患者提供一种新的治疗策略.
- 需要进一步的临床研究来验证Lactobacillus在治疗T2DM牙周炎中的应用.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Carbohydrate Metabolism
11.2K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
11.2K
Glucagon-like Receptor Agonists
327
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
327
Pathophysiology of Diabetes
949
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
949
Diabetes Mellitus: Overview and Type I Subtype
2.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.7K
Diabetes: Management and Pharmacotherapy
288
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
288


